PHD2 was significantly overexpressed in AML patients, which shows that PHD2-mediated proline hydroxylation is a potential oncogenic pathway in AML, driving BRD4-mediated gene expression and cancer cell proliferation (88). The gene discussed is EGLN1; the disease is acute myeloid leukemia.